Neurointerventional oncology: the new frontier
The Society of NeuroInterventional Surgery (SNIS) convened the inaugural Neuro Interventional Oncology (NIO) summit at M D Anderson Cancer Center in Houston, Texas on April 26–27, 2024. Physician, scientist, and industry attendees discussed the state of the field and established goals for multidisciplinary, multi-institutional clinical research investigation in this increasingly important field. SNIS members and guests in attendance are listed at the end of this commentary. Here we describe the motivation for this meeting and outline goals for NIO. Although transcatheter (primarily intracarotid) delivery of chemotherapeutic agents to the brain has been previously piloted,1 2 several recent developments have reinvigorated interest in this approach. First, enhanced molecular/genetic testing has greatly enhanced our biologic understanding of central nervous system (CNS) and CNS-adjacent malignancies. Second, improvements in neurointerventional techniques and imaging, driven by growth of e
